Security Class: Common Shares
FORM OF PROXY
Annual General & Special Meeting to be held on WEDNESDAY, MAY 18, 2022
This Form of Proxy is solicited by and on behalf of Management.
Notes to proxy
Every holder has the right to appoint some other person or company of their choice, who need not be a holder, to attend and act on their behalf at the meeting or any adjournment or postponement thereof. If you wish to appoint a person or company other than the persons whose names are printed herein, please insert the name of your chosen proxyholder in the space provided (see reverse).
If the securities are registered in the name of more than one owner (for example, joint ownership, trustees, executors, etc.), then all those registered should sign this proxy. If you are voting on behalf of a corporation or another individual you must sign this proxy with signing capacity stated, and you may be required to provide documentation evidencing your power to sign this proxy.
This proxy should be signed in the exact manner as the name(s) appear(s) on the proxy.
If this proxy is not dated, it will be deemed to bear the date on which it is mailed by Management to the holder.
If you appoint the Management Nominees to vote your securities, they will vote in accordance with your instructions or, if no instructions are given, in accordance with the Management Voting Recommendations highlighted for each Resolution overleaf. If you appoint someone else to vote your securities, they will also vote in accordance with your instructions or, if no instructions are given, as they in their discretion choose.
This proxy confers discretionary authority in respect of amendments or variations to matters identified in the Notice of Meeting or other matters that may properly come before the meeting or any adjournment or postponement thereof.
This proxy should be read in conjunction with the accompanying documentation provided by Management.
Proxies submitted must be received by 10:00 am, Pacific Daylight Savings Time, on Monday May 16, 2022, or in the case of any adjournment or postponement of the Meeting not less than 48 hours (Saturdays, Sundays and holidays excepted) before the time of the adjourned or postponed meeting.
VOTING METHODS | |
MAIL or HAND DELIVERY | Endeavor Trust Corporation 702 - 777 Hornby Street Vancouver, BC V6Z 1S4 |
FACSIMILE - 24 Hours a Day | 604-559-8908 |
proxy@EndeavorTrust.com | |
ONLINE | As listed on Form of Proxy or Voter Information Card |
If you vote by FAX, EMAIL or On-Line, DO NOT mail back this proxy.
Voting by mail may be the only method for securities held in the name of a corporation or securities being voted on behalf of another individual.
Voting by mail, fax or by email are the only methods by which a holder may appoint a person as proxyholder other than the Management nominees named on the reverse of this proxy.
Appointment of Proxyholder
I/We, being holder(s) of GENIX | Print the name of the person you are | |
PHARMACEUTICALS CORPORATION | OR | appointing if this person is someone other |
hereby appoint: Paul Chow, Director or | than the Management Nominee listed | |
failing him, Kevin Bottomley, Director or | herein. | |
if failing him Jamie Lewin, Director. |
as my/our proxyholder with full power of substitution and to attend, act and to vote for and on behalf of the shareholder in accordance with the following direction (or if no directions have been given, as the proxyholder sees fit) and all other matters that may properly come before the Annual General & Special Meeting of shareholders of GENIX PHARMACEUTICALS CORPORATION to be held at 1100-1111 Melville Street, Vancouver BC V6E 3V6 on Wednesday, May 18, 2022 at 10:00 am, Pacific Daylight Savings Time, and at any adjournment or postponement thereof.
VOTING RECOMMENDATIONS ARE INDICATED BY HIGHLIGHTED TEXT OVER THE BOXES.
1. Number of Directors | For | Against |
The number of Directors shall be set to 6 (six); | □ | □ |
2. Election of Directors | For | Withheld |
□ | □ | |
i) Sina Salehi Pirooz | ||
□ | □ | |
ii) Jamie Lewin | ||
□ | □ | |
iii) Kevin Bottomley | ||
□ | □ | |
iv) Darryl Yea | ||
□ | □ | |
v) Paul Chow | ||
□ | □ | |
vi) Mahmoud Aziz | ||
3. Appointment of Auditor | For | Withheld |
□ | □ | |
To appoint Harbourside CPA, Chartered Accountants, as auditor of the Company for the ensuing year and | ||
to authorize the directors to fix their remuneration; | ||
4. Approval of Stock Option plan | For | Against |
To approve the ordinary resolution as more particularly set forth in the Management information Circular, | □ | □ |
approving the 10% rolling Stock Option Plan of the Company. | ||
5. Other Matters | For | Against |
To transact such other business that may be brought properly before the Meeting and any adjournment or | □ | □ |
postponement of the Meeting. |
Authorized Signature(s) - This section must be | Signature(s) |
completed for your instructions to be executed. | |
I/We authorize you to act in accordance with my/our | |
instructions set out above. I/We hereby revoke any proxy | ______________________________________________________ |
previously given with respect to the Meeting. If no voting | Print Name(s) & Signing Capacity(ies), if applicable |
instructions are indicated above, this Proxy will be voted | |
as recommended by Management. | |
__________________________________ | |
To receive all future proxy materials by electronic delivery, | Date (MM-DD-YY) |
check the box below. | THIS PROXY MUST BE DATED |
□ Email Address: ___________________________________________
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
GenixPharmaceuticals Corporation published this content on 27 April 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 27 April 2022 04:04:03 UTC.